Breakthroughs in diagnostics and therapeutics around cancer through exosomes are advancing, but the solutions for getting exosomes from fluids is challenging. Clara Biotech introduces a new isolation paradigm providing the only platform that can isolate any exosome, from any biofluid at scale. Pure, intact, viable and suitable for any use. Our technology moves cutting edge research to patient. We currently service customers from Pharma to Research.
Connect with Clara Biotech